Article
The future of therapeutic options for hereditary angioedema.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology - 1 Oct 2024
Smith Tukisa D, Riedl Marc A
Abstract excerpt
Hereditary angioedema (HAE) is a rare genetic condition causing unpredictable and severe episodes of angioedema that are debilitating and life-threatening. Moreover, HAE can be classified into HAE due to C1-esterase inhibitor deficiency (HAE-C1INH) or HAE with normal C1INH. Moreover, HAE-C1INH is subcategorized as types I and II based on deficient or dysfunctional circulating C1INH protein resulting from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.